Trade Summary

4 days ago, TETRAULT LYNN A., serving as Dir at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 37,000 shares at $100.32 per share, for a total transaction value of $3,711,895.50. Following this transaction, TETRAULT LYNN A. now holds 7,000 shares of RYTM.

This sale represents a 84.09% decrease in TETRAULT LYNN A.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, June 22, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, June 24, 2026 at 4:15 PM ET, 2 days after the trade was made.

RHYTHM PHARMACEUTICALS, INC. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.